1-4 of 4
Thomas Schmitt
Close
Sort by
Journal Articles

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen

Sebastian Ochsenreither, Ravindra Majeti, Thomas Schmitt, Derek Stirewalt, Ulrich Keilholz, Keith R. Loeb, Brent Wood, Yongiae E. Choi, Marie Bleakley, Edus H. Warren, Michael Hudecek, Yoshiki Akatsuka, Irving L. Weissman, Philip D. Greenberg
Journal: Blood
Blood (2012) 119 (23): 5492–5501.
https://doi.org/10.1182/blood-2011-07-365890
Published: 2012
Includes: Supplemental data
Journal Articles

A Multicenter Retrospective Analysis on Pentostatin As Salvage Therapy of Severe Steroid Refractory Intestinal Acute Graft Versus Host Disease

Stefan A. Klein, Thomas Schmitt, Gesine Bug, Johannes Schetelig, Rainer Schwerdtfeger, Kerstin Schaefer-Eckart, Christoph Schmid, Hannes Wandt, Wolf-Karsten Hofmann, Martin Bornhaeuser, Hans Martin, Peter Dreger
Journal: Blood
Blood (2011) 118 (21): 3048.
https://doi.org/10.1182/blood.V118.21.3048.3048
Published: 2011
Journal Articles

Pentostatin for First-Line Salvage Therapy of Steroid-Refractory Intestinal Acute Graft-Versus-Host Disease; a Dual Center Retrospective Analysis

Stefan A. Klein, Thomas Schmitt, Gesine Bug, Thomas Luft, Sabine Mousset, Ute Hegenbart, Wolf-Karsten Hofmann, Anthony D. Ho, Hans Martin, Peter Dreger
Journal: Blood
Blood (2010) 116 (21): 1274.
https://doi.org/10.1182/blood.V116.21.1274.1274
Published: 2010
Journal Articles

Poor Mobilization of Hematopoietic Stem Cells – Definitions, Incidence, Risk Factors and Impact On Outcome of Autologous Transplantation.

Patrick Wuchter, MD, Dan Ran, Thomas Schmitt, MD, Tom Bruckner, PhD, Mathias Witzens-Harig, MD, Hartmut Goldschmidt, MD, Anthony D. Ho, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2153.
https://doi.org/10.1182/blood.V114.22.2153.2153
Published: 2009